相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy
Jiayu Zhao et al.
BIOMATERIALS (2021)
A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase
Jiankun Guan et al.
BIOMATERIALS (2021)
A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
Shiyang Shen et al.
NATURE NANOTECHNOLOGY (2021)
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Jing Liu et al.
NATURE COMMUNICATIONS (2021)
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
Raul Ortiz et al.
CANCERS (2021)
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy
Zhiren Wang et al.
NATURE NANOTECHNOLOGY (2021)
Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model
Daniel Thorpe et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy
Quan Zhou et al.
NATURE NANOTECHNOLOGY (2019)
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu et al.
NATURE COMMUNICATIONS (2019)
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
Xiangsheng Liu et al.
ACS NANO (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu et al.
NATURE COMMUNICATIONS (2017)
Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate
Ladislav Sivak et al.
BIOMATERIALS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy
Haijie Han et al.
NANOSCALE (2016)
Expanding antigen-specific regulatory networks to treat autoimmunity
Xavier Clemente-Casares et al.
NATURE (2016)
Perspectives on Biologically Active Camptothecin Derivatives
Ying-Qian Liu et al.
MEDICINAL RESEARCH REVIEWS (2015)
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD- fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
N. Werthmoeller et al.
CELL DEATH & DISEASE (2015)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT
W. J. F. M. van der Velden et al.
BONE MARROW TRANSPLANTATION (2013)
Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function
Roberto Martinez-Beamonte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution
Goril Eide Flaten et al.
JOURNAL OF LIPOSOME RESEARCH (2013)
Glutathione levels in human tumors
Michael P. Gamcsik et al.
BIOMARKERS (2012)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
Roberta Zappasodi et al.
CANCER RESEARCH (2010)
Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature
Vincent J. Venditto et al.
MOLECULAR PHARMACEUTICS (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Inorganic Metal Hydroxide Nanoparticles for Targeted Cellular Uptake Through Clathrin-Mediated Endocytosis
Jae-Min Oh et al.
CHEMISTRY-AN ASIAN JOURNAL (2009)
Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis
Andrea M. Stringer et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Methotrexate-induced mucositis in mucin 2-deficient mice
Barbara A. E. De Koning et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy
DC Drummond et al.
CANCER RESEARCH (2006)
Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models
T Schluep et al.
CLINICAL CANCER RESEARCH (2006)
A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system
Ho Lun Wong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Yong Wang et al.
CURRENT CANCER THERAPY REVIEWS (2006)
Normal structure, function, and histology of the bone marrow
Gregory S. Travlos
TOXICOLOGIC PATHOLOGY (2006)
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
In vitro conversion of irinotecan to SN-38 in human plasma
M Shingyoji et al.
CANCER SCIENCE (2004)
Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer
K Ohtsuka et al.
LUNG CANCER (2003)
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Y Xu et al.
ANNALS OF ONCOLOGY (2002)
Polymer-bound camptothecin: initial biodistribution and antitumour activity studies
VR Caiolfa et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
